Immunovant, Inc. (IMVT) Discusses Brepocitinib Program Expansion and Batoclimab Phase III Data Update - Slideshow
The Big Market Report Take
Summary unavailable.
Not financial advice. The Big Market Report aggregates news for informational purposes only. Nothing on this site constitutes investment advice. Equities and other securities are subject to market risk. Always do your own research and consult a qualified financial advisor before making any investment decisions. Full disclaimer →
Never miss a story
More from this section
- MIT Media Lab Working to Advance Women's HealthBloomberg Markets37m ago
- Canada’s Irving Turns to Newfoundland for Oil on Iran DisruptionBloomberg Markets43m ago
- Ex-Centerview Banker Gets Deal to End US Insider-Trading CaseBloomberg Markets43m ago